Scientists Bioengineer A Protein To Fight Leukemia
2/19/2011
Scientists at the Children's Center for Cancer and Blood Diseases and The Saban Research Institute of Children's Hospital Los Angeles today announced a breakthrough discovery in understanding how the body fights leukemia...
Top Institute Pharma (TI Pharma) is launching a new research project that should make stem cell transplants more successful. A stem cell transplant is usually performed on adults with acute leukemia...
Macmillan Responds To NICE's Decision On Cancer Drug Azacitidine
2/18/2011
Responding to the decision by NICE to recommend Azacitidine as a treatment for myelodyplastic syndrome, chronic myelomonocytic leukaemia, and acute myeloid leukaemia, Mike Hobday, Head of Policy at Macmillan Cancer Support, said: 'This is superb news for cancer patients with rarer cancers...
New Hope For Baby Boomers With Leukemia And Lymphoma
2/18/2011
As the first baby boomers turn 65, Loyola University Hospital has begun offering stem cell transplants to leukemia and lymphoma patients who previously were too old to qualify. Hospitals traditionally have not offered stem cell transplants to patients older than 60 due to potentially severe complications. But Loyola now offers this treatment to patients in their 60s and early 70s...
The European Medicines Agency has been formally notified by Sun Pharmaceutical Industries B.V. of its decision to withdraw its application for a centralised marketing authorisation for the medicinal product Topotecan SUN (topotecan) 1 mg and 4 mg powder for concentrate for solution for infusion...
BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) announced the successful delivery of its first lung cancer patient treatment with the MicroThermX® Microwave Ablation System. The treatment was conducted by Damian E. Dupuy, M.D., at The Comprehensive Cancer Center at Rhode Island Hospital (Rhode Island Hospital) in Providence, Rhode Island. Dr...
Researchers Believe Discovery Could Lead To Testing That Displaces Colonoscopies
2/18/2011
Nobody enjoys colonoscopies, including mice. University of Missouri researchers are excited about the potential of using genetic biomarkers to predict colon cancer caused by inflammation. A new method developed at the MU Research Animal Diagnostic Laboratory (RADIL) could eventually lead to a method that might eliminate colonoscopies altogether...
In draft guidance issued today, NICE recommends azacitidine (Vidaza, Celgene) as a treatment option for people with the following conditions who are not eligible for haematopoietic stem cell transplantation: intermediate-2 and high-risk myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia...
Enzyme Helps Prepare Lung Tissue For Metastatic Development
2/17/2011
A Massachusetts General Hospital (MGH) study has identified a new role for an important enzyme in preparing lung tissue for the development of metastases...
Genomic Health, Inc...